Abamune L Tablet

About Abamune L Tablet

Abamune L Tablet is used for the treatment of HIV-1 infection in adults and children, combining two nucleoside reverse transcriptase inhibitors (NRTIs) in a single convenient tablet. Each tablet contains 600mg of Abacavir and 300mg of Lamivudine, both of which work synergistically to suppress viral replication by inhibiting the reverse transcriptase enzyme essential for HIV reproduction. Manufactured by Cipla Limited, this fixed-dose combination simplifies antiretroviral therapy by reducing pill burden and improving adherence. Patients managing complex medication regimens, similar to those using Atazor R Tablet (Atazanavir/Ritonavir) for protease inhibition, often find combination therapy more manageable for long-term HIV management. The dual-action formula prevents the virus from multiplying in the body, helping to maintain immune function and reduce the risk of opportunistic infections, though it does not cure HIV or prevent transmission to others.

Dosage & Usage

To take Abamune L Tablet correctly, adults and adolescents weighing at least 25kg should take one tablet once daily, with or without food. The tablet should be swallowed whole with water and taken at approximately the same time each day to maintain consistent drug levels in the bloodstream. Never adjust your dose without consulting your healthcare provider, as maintaining strict adherence is critical for preventing viral resistance. Before initiating treatment, patients must undergo HLA-B*5701 allele screening, as individuals carrying this genetic marker face significantly increased risk of potentially fatal hypersensitivity reactions. Missing doses or stopping treatment abruptly can lead to drug resistance and treatment failure, making adherence paramount for optimal outcomes in HIV management.

Who Is It For?

Abamune L Tablet is safe for adults and adolescents weighing over 25kg who have tested negative for the HLA-B*5701 allele and require combination antiretroviral therapy for HIV-1 infection. It is not suitable for individuals with moderate to severe hepatic impairment, those with creatinine clearance below 50 mL/min, or patients who have previously experienced hypersensitivity reactions to abacavir or lamivudine. Pregnant and breastfeeding women should discuss risks and benefits with their healthcare provider, as HIV transmission prevention must be carefully balanced with maternal and infant safety. Patients requiring multiple life-saving medications, such as those also prescribed Acabrunat 100mg (Acalabrutinib) for other conditions, must inform their physician of all medications to avoid dangerous drug interactions. Those with underlying liver disease, history of pancreatitis, or cardiac risk factors require close monitoring during treatment.

Why Buy From SafeRxPills?

SafeRxPills is a fully licensed international pharmacy serving patients in Australia, the United Kingdom, the United States, and Canada with genuine life-saving medications at competitive prices. We provide discreet packaging and reliable shipping within 7-14 business days, ensuring your treatment arrives safely and confidentially. Our pharmacists are available to answer questions about your antiretroviral therapy and help coordinate refills to prevent treatment interruptions. Every medication is sourced directly from certified manufacturers like Cipla Limited, guaranteeing authenticity and quality. With secure payment options and comprehensive customer support, SafeRxPills makes accessing essential HIV treatment straightforward and affordable for patients worldwide.